Edition:
United States

Ligand Pharmaceuticals Inc (LGND.OQ)

LGND.OQ on NASDAQ Stock Exchange Global Market

134.25USD
26 Jul 2016
Change (% chg)

$0.65 (+0.49%)
Prev Close
$133.60
Open
$133.60
Day's High
$135.00
Day's Low
$132.32
Volume
85,450
Avg. Vol
138,438
52-wk High
$138.68
52-wk Low
$71.63

LGND.OQ

Chart for LGND.OQ

About

Ligand Pharmaceuticals Incorporated (Ligand) is a biopharmaceutical company that focuses on developing and acquiring technologies that help pharmaceutical companies discover and develop medicines. The Company employs research technologies, such as nuclear receptor assays, high throughput computer screening, formulation science,... (more)

Overall

Beta: 1.09
Market Cap(Mil.): $2,781.88
Shares Outstanding(Mil.): 20.82
Dividend: --
Yield (%): --

Financials

  LGND.OQ Industry Sector
P/E (TTM): 10.93 41.28 37.71
EPS (TTM): 12.23 -- --
ROI: 61.46 -9.20 14.43
ROE: 122.85 -9.24 15.61

BRIEF-Ligand enters into Omniab platform license agreement with Gilead Sciences

* Ligand enters into Omniab platform license agreement with Gilead Sciences

Jul 08 2016

BRIEF-Ligand receives $4 mln from expansion of two OmniAb license agreements

* Ligand Pharmaceuticals Inc says anticipates total revenue for Q2 of 2016 to be approximately $19 million

Jun 30 2016

BRIEF-Ligand reports Q1 earnings per share of $0.30

* Q1 earnings per share view $0.67 -- Thomson Reuters I/B/E/S

May 04 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : Stock Traders Daily
$20.00
Provider : New Constructs, LLC
$25.00
Provider : ValuEngine, Inc.
$25.00
Provider : Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.